Office of Sponsored Programs
OSP Weekly
05/01/2019
|
|
Please forward and share with other faculty who may be interested.
|
|
Minority Research Grant Program
LOI Highly Encouraged by: 05/10/2019
Application Deadline: 06/17/2019, 3:00 PM ET
The Centers for Medicare & Medicaid Services (CMS) Office of Minority Health (OMH) is announcing the availability of funds under the Minority Research Grant Program to test promising solutions that achieve health equity. The purpose of the Grant Program is to support researchers investigating health processes, practices, behaviors, and burdens or issues that influence health equity and, in particular, address the social determinants of health. The Grant Program is an opportunity to support health disparitities researchers at 1) Historically Black Colleges and Universities (HBCUs), 2) Hispanic Serving Institutions (HSIs), 3) Asian American and Native American Pacific Islander-Serving Institutions (AANAPISIs), or 4) Tribal Colleges and Universities (TCUs).
|
|
Notice of Special Interest to Highlight High Priority Research Opportunities on Suicide Prevention Crisis Services
First Available Due Date: 06/05/2019
Care for suicide crises is often fragmented, with crisis services being provided by on-call therapists or in crowded emergency departments. As a result, some individuals at risk for suicide may fail to receive appropriate services and follow-up, leading to multiple re-admissions, involvement with the criminal justice system, or even a suicide death. Consistent with its efforts to prioritize applied suicide prevention research, NIMH is issuing this Notice to highlight its interest in receiving grant applications focused on applied research that advances the
N
ational Action Alliance for Suicide Prevention's
Crisis Services Task Force efforts, summarized in the report,
Crisis Now: Transforming Ser
vices is Within Our Reach
.
|
|
The Gus Schumacher Nutrition Incentive Program
Application Deadline: 06/10/2019, 5:00 pm ET
Informational Webinar: 05/15/2019 2:00 pm ET - see RFA for details
FON: USDA-NIFA-FINI-006771
AGENCY:
National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (USDA)
To support projects to increase the purchase of fruits and vegetables among low-income consumers participating in the Supplemental Nutrition Assistance Program (SNAP) by providing incentives at the point of purchase. The program will test strategies that could contribute to our understanding of how best to increase the purchase of fruits and vegetables by Supplemental Nutrition Assistance Program (SNAP) participants.
|
|
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
LOI Deadline: 30 days prior to application deadline by 5:00 pm PT
Application Deadline: 07/22/2019, 5:00 PM PT
FON: PAR-19-258
AGENCY: National Institutes of Health (NIH), Department of Health and Human Services (HHS) , National Institute on Drug Abuse (NIDA)
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDA R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. This FOA is intended to support research education activities that enhance the knowledge of substance use and substance use disorder research. The program is intended for those in clinically focused careers and/or those training for careers as clinicians/health service providers, clinical researchers, or optimally a combination of the two. This mechanism may not be used to support non-research-related clinical training.
|
|
Computer and Information Science and Engineering (CISE) Research Initiation Initiative
Application Deadline: 08/14/2019, 5:00 pm PT
FON: 19-579
AGENCY: Directorate for Computer & Information Science & Engineering (CISE), National Science Foundation (NSF)
The NSF Directorate for Computer and Information Science and Engineering (CISE) seeks to award grants intended to support research independence among early-career academicians who specifically lack access to adequate organizational or other resources. It is expected that funds obtained through this program will be used to support untenured faculty or research scientists (or equivalent) in their first three years in a primary academic position after the PhD, but not more than five years after completion of their PhD. Applicants for this program may not yet have received any other grants or contracts in the PI role from any department, agency, or institution of the federal government, including from the CAREER program or any other program, post-PhD, regardless of the size of the grant or contract, with certain exceptions as noted.
|
|
School of Medicine Opportunities
|
|
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
|
|
Request for Proposals (RFP)
Unmet Needs in the Treatment of Psoriatic Arthritis (PsA)
|
|
Date RFP Issued
: April 15, 2019
Geographic Scope
:
United States ONLY
Clinical Area
: Psoriatic Arthritis (PsA)
Application Due Date
: June 10, 2019
Specific Area of Interest
:
It is our intent to support educational projects that improve the overall care and diagnosis of patients with PsA by increasing healthcare provider knowledge and management of the disease state, including an understanding of comorbidities as well as the unmet needs in the treatment of PsA.
|
|
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, free lodging near treatment centers, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is the only organization attacking cancer from every angle.
|
|
Request for Proposals (RFP)
Integrated Approach to Breast Health Equity
|
|
Date RFP Issued
: April 22, 2019
Geographic Scope
:
United States ONLY
Clinical Area
: Breast Cancer
Application Due Date
: June 17, 2019
Specific Area of Interest
:
The intent of this community grants project is to focus on reducing the widening gap in breast cancer mortality trends between black and white patients.
It is expected that projects will be evidence-based (education and/or quality improvement) and the proposed research/evaluation plan will follow generally accepted scientific principles. During review, the intended outcome(s) of the project will be given careful consideration and projects with the maximum likelihood to directly impact patient care will be given high priority.
|
|
Refer to complete details in the
full RFP document
. If you have questions regarding this RFP, please direct them in writing to the Pfizer Grant Officer, Jacqueline Waldrop (
[email protected]
) or to Karla Wysocki at the American Cancer Society (
[email protected]
).
|
|
The Lung Cancer Research Foundation and Pfizer Global Medical Grants are collaborating to offer a new research grant opportunity focused on understanding ways to improve clinical practices for side effect management for non-small cell lung cancer (NSCLC) patients receiving targeted therapies.
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
The Lung Cancer Research Foundation (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. The foundation’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer. Through its scientific grant program, LCRF has funded 362 research grants totaling $33 million since inception.
|
|
Request for Proposals (RFP)
Improving Duration of Therapy and Outcomes in NSCLC Patients Receiving Targeted Therapy
|
|
Date RFP Issued
: April 29, 2019
Geographic Scope
:
United States ONLY
Clinical Area
: Lung Cancer
Application Due Date
: June 24, 2019
Specific Area of Interest
:
The intent of this RFP is to support innovative health services research proposals that leverage multidisciplinary approaches to improve the management of targeted therapy toxicities. Proposals on a variety of topics including the following are encouraged:
- Patterns of real-world versus pre-approval patient side-effect experiences
- Defining and understanding tolerability (including late toxicities and patient reported outcomes)
- Role of diverse, multi-disciplinary teams (including pharmacists, dieticians, caregivers, etc.) and coordination of care in managing and monitoring therapy
- Real-time symptom monitoring
- Implementation science approaches to improving care delivery
|
|
|
|
|
|
|
